Bioequivalence Study of Perindopril /Amlodipine/Indapamide 8 mg (10 mg)/2.5 mg/10 mg Tablets in Healthy Volunteers Under Fasting Conditions

Condition:   Bioequivalence Intervention:   Drug: Perindopril/Indapamide/Amlodipine 8 mg/2.5 mg/10 mg tablet / Triplixam® 10 mg/2.5 mg/10 mg tablet Sponsor:   Pharmtechnology LLC Recruiting

Source: ClinicalTrials.gov - July 11, 2023 Category: Research Source Type: clinical trials